Suman

Siam

Shradha

Ritesh

Rahul

Prem

Narayan

Himesh

Biswajit

Arti
Approved

US approves new Covid antibody drug for high-risk population

U.S. officials have authorized a new COVID-19 antibody drug for people with serious health problems or allergies who can’t get adequate protection from vaccination. The Food and Drug Administration granted emergency use Wednesday to the drug combo made by A...

9 December, 2021

Read more
agreement

Dr. Reddy’s, Prestige BioPharma partner for cancer drug

Dr. Reddy’s Laboratories has formed a partnership with Prestige BioPharma under which it will have exclusive rights to sell and market the Singapore company’s proposed trastuzumab biosimilar in Latin America and Southeast Asia. Prestige BioPharm...

9 December, 2021

Read more
booster shots

Three shots of BioNTech, Pfizer neutralizes Omicron

In a laboratory test, BioNTech and Pfizer stated on Wednesday that a three-shot course of their COVID-19 vaccine was able to neutralise the novel Omicron strain, and that an Omicron-based vaccine could be delivered in March 2022 if needed. BioNTech and Pfiz...

9 December, 2021

Read more
t cells

Study suggests GSK’s Covid antibody treatment works against Omicron

GlaxoSmithKline Plc, a pharmaceutical business, said that their antibody treatment for Covid-19 is effective against the whole combination of mutations in the novel strain omicron. The drugmaker in a statement said the tests done in-vitro against a pseudo-v...

7 December, 2021

Read more

Adults need a second Covid-19 booster injection: Moderna

19 March, 2022

Prescribes Raids on Erring Pharma Firms, Health Ministry has asked ...

17 March, 2022

New York state data on Pfizer/BioNTech vaccine has EMA unconcerned

4 March, 2022

Moderna’s Covid Jab Gets EU Approval For Kids Aged 6-11

25 February, 2022

mRNA Covid vaccine scientist Dr Weissman and team working on develo...

24 February, 2022

Biological E’s Corbevax gets DCGI nod

22 February, 2022

Sources say CDL Kasauli cleared around 6.5 crore doses of Corbevax

22 February, 2022

Lupin’s antibiotic drug gets USFDA nod

18 February, 2022

Moderna expecting Covid-19 booster by August, unsure on Omicron spe...

17 February, 2022

Pfizer and BioNTech Omicron vaccine delayed: BioNTech CEO

17 February, 2022

Israel approves AstraZeneca Covid drug for people with weak immunity

16 February, 2022

Biological E seeks EUA for its Corbevax vaccine for 12-18 yrs age g...

14 February, 2022

China approves Pfizer’s Covid drug Paxlovid

12 February, 2022

Emcure Pharma arm developing Omicron specific Covid vaccine

11 February, 2022

DCGI nod to SII to make COVID vaccine against Omicron for test, ana...

8 February, 2022

Sputnik Light the second vaccine to be made available in India by D...

7 February, 2022

Pfizer asks FDA to allow Covid-19 vaccine for children under 5

2 February, 2022

Nasal Covid-19 vaccine to be a gamechanger: AIIMS epidemiologist

31 January, 2022

Moderna begins trial of Omicron specific vaccine

27 January, 2022

Covishield, Covaxin to be capped at ₹ 275 each post getting marketi...

27 January, 2022